JOSSE MAZO-MAYORQUIN: Open Payments
NPI 1447256284 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 44 payments from 23 companies in 2025. Trend: 2023 $1,063 · 2024 $1,027 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $170 |
| UCB, Inc. | 4 | $103 |
| Eisai Inc. | 3 | $80 |
| Lundbeck LLC | 2 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| EMD Serono, Inc. | 2 | $50 |
| C2N Diagnostics, LLC | 2 | $50 |
| Tanabe Pharma America, Inc. | 2 | $46 |
| ARGENX US, INC. | 2 | $40 |
| Neurelis, Inc. | 2 | $38 |
Products named: UBRELVY, Leqembi, VYEPTI, QULIPTA, INGREZZA, Briviact, PRECIVITYAD2, Radicava.
Industry payments across FL — which companies pay providers there.
